SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OSI Pharmaceuticals (OSIP) - formerly Oncogene
An SI Board Since December 1997
Posts SubjectMarks Bans Symbol
447 40 0 OSIP
Emcee:  James Reynolds Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
247OSI Pharmaceuticals Grants License to Merck & Co., Inc. Under Patent Coverinnigel bates-6/30/2005
246[CHMP (like ODAC) positive opinion for Tarceva in EU] >>MELVILLE, N.Y.--(tuck-6/27/2005
245OSI Pharmaceuticals Announces Tarceva Granted First European Approval in Switzerfred hayes-3/22/2005
244OSIP related AACR abstracts. abstractonline.com ==============================sim1-3/15/2005
243Said they were unable to distinguish it from a competitor's version. (I'Biomaven-2/14/2005
242Just FYI... in the transition 10Q filed today, OSI notes that they've cannedformer_pgs-2/9/2005
241[OSI-211 dose finding trial in ovarian cancer] >>JCO Early Release, publituck-2/8/2005
240This is a link to the Journal of Clinical Oncology article* suggesting that presIRWIN JAMES FRANKEL-1/27/2005
239OSIP I posted this comment and question on Yahoo. I will post the answer if I gIRWIN JAMES FRANKEL-1/27/2005
238ZURICH (Dow Jones)--Roche Holding AG (RHHBY) said Thursday that data from a studIRWIN JAMES FRANKEL-1/27/2005
237Tarceva-Gemzar combo prolongs life in cancer trial Thu Jan 27, 2005 10:59 AM ET IRWIN JAMES FRANKEL-1/27/2005
236Congrat to OSIP holders. Surprise is second line settings, so we need to se fulMiljenko Zuanic-11/18/2004
235Dr. Colin Goddard: There's an outstanding question, that absolutely fascinascaram(o)uche-11/16/2004
234I'm not sure about the significance of the news - I'm no expert or even Paul Senior-9/20/2004
233Dr. Colin Goddard: There's an outstanding question, that absolutely fascinascaram(o)uche-9/20/2004
232>>MELVILLE, N.Y. & SOUTH SAN FRANCISCO, Calif. & BASEL, Switzerlantuck-9/20/2004
231These tyrosine-kinase inhibitors only seem to work on 10% of the population. A A.J. Mullen-7/27/2004
230Dr. Colin Goddard: There's always this outstanding question, that absolutelscaram(o)uche-7/7/2004
229Research Report on OSIP biotechstocksignals.comTom Ronk-6/23/2004
228Meanwhile, Aptosyn fails yet again. Tarceva is fine, but OSI's taste in protuck-6/14/2004
227here' s the reference to smokers: biz.yahoo.comtechtonicbull-6/9/2004
226No No. Smokers haven't shown help from Tarceva.techtonicbull-6/9/2004
225Where did the story arise that Tarceva hasn't shown usefulness in smokers? Itechtonicbull-6/9/2004
224Also, why is there talk that Tarceva doesn't work well in smokers?techtonicbull-6/9/2004
223Have you heard that Tarceva is not shown usefulness in smokers with lung cancer?techtonicbull-6/9/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News